Add to ORKGThe emergence and spread of M. tuberculosis multidrug-resistant (MDR-TB), extensively drug-resistant (XDR-TB) and, more recently, totally drug-resistant (TDR) strains is a an extremely dangerous threat to public health, in particular to immunocompromised patients. Hence, there is a great need for new drugs that provide shorter, safer, cheaper and more effective treatment alternatives for active and latent TB infection, MDR and XDR-TB, and that have minimal interactions with antiretroviral drugs
ABSTRACT Multidrug-resistant and extensively drug-resistant tuberculosis (MDR-TB and XDR-TB, respect...
Tuberculosis (TB) is the ninth cause of global death, more than any other infectious disease. With g...
Drug resistance is a major hurdle in the global battle against tuberculosis (TB). In tackling this p...
The emergence and spread of M. tuberculosis multidrug-resistant (MDR-TB), extensively drug-resistant...
Despite the development of effective treatments, tuberculosis (TB) remains a major health problem. T...
International audienceRecently, multidrug-resistant tuberculosis (MDR-TB) has become a therapeutic c...
Tuberculosis (TB) remains the major health problem causing morbidity and mortality throughout the wo...
Tuberculosis (TB) is a major global health threat. The emergence of human immunodeficiency virus (HI...
Emergence of drug resistant tuberculosis like multi drug resistant tuberculosis (MDR-TB), extensivel...
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant TB (XDR-TB) are increasing ...
For the first time in 40 years, a portfolio of promising new compounds for the treatment of tubercul...
WHO estimates that 9 million people developed active tuberculosis in 2013 and 1.5 million people die...
International audienceDespite the low expensive and effective four-drug treatment regimen (isoniazid...
Treatment of multidrug-resistant tuberculosis (MDR-TB) cases is challenging because it relies on sec...
Tuberculosis (TB) continues to cause more deaths worldwide than any other single infectious disease....
ABSTRACT Multidrug-resistant and extensively drug-resistant tuberculosis (MDR-TB and XDR-TB, respect...
Tuberculosis (TB) is the ninth cause of global death, more than any other infectious disease. With g...
Drug resistance is a major hurdle in the global battle against tuberculosis (TB). In tackling this p...
The emergence and spread of M. tuberculosis multidrug-resistant (MDR-TB), extensively drug-resistant...
Despite the development of effective treatments, tuberculosis (TB) remains a major health problem. T...
International audienceRecently, multidrug-resistant tuberculosis (MDR-TB) has become a therapeutic c...
Tuberculosis (TB) remains the major health problem causing morbidity and mortality throughout the wo...
Tuberculosis (TB) is a major global health threat. The emergence of human immunodeficiency virus (HI...
Emergence of drug resistant tuberculosis like multi drug resistant tuberculosis (MDR-TB), extensivel...
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant TB (XDR-TB) are increasing ...
For the first time in 40 years, a portfolio of promising new compounds for the treatment of tubercul...
WHO estimates that 9 million people developed active tuberculosis in 2013 and 1.5 million people die...
International audienceDespite the low expensive and effective four-drug treatment regimen (isoniazid...
Treatment of multidrug-resistant tuberculosis (MDR-TB) cases is challenging because it relies on sec...
Tuberculosis (TB) continues to cause more deaths worldwide than any other single infectious disease....
ABSTRACT Multidrug-resistant and extensively drug-resistant tuberculosis (MDR-TB and XDR-TB, respect...
Tuberculosis (TB) is the ninth cause of global death, more than any other infectious disease. With g...
Drug resistance is a major hurdle in the global battle against tuberculosis (TB). In tackling this p...